Windtree Faces Nasdaq Delisting as BNB Treasury Pivot Falters
Windtree, the struggling biotech that rebranded itself as a BNB treasury firm, is facing imminent delisting from the Nasdaq after failing to meet minimum share price requirements. Nasdaq Delisting...
